Press Releases

 

Scientific Articles

2019

Cloarex R, Riffault B, Dufour A, Rabiei H, Gouty-Colomer LA, Dumon C, Guimond D, Bonifazi P, Eftekhari S, Lozovaya N, Ferrari DC, Ben-Ari Y.
Pyramidal neuron growth and increased hippocampal volume during labor and birth in autism. Science Advances, 23 Jan 201; 5-1.
Source

2018

Fernandez A,Dumon C,Guimond D, Tyzio R,Bonifazi P, Lozovaya N,Burnashev N,Ferrari DC, Ben-Ari Y.
The GABA Developmental Shift Is Abolished by Maternal Immune Activation Already at Birth. Cerebral Cortex, 2018; 1-11.
Download the paper

Lozovaya N, Ben-Ari Y, Hammond C.
Striatal dual cholinergic/GABAergic transmission in Parkinson disease: friends or foes? Cell Stress, 2018; 2(6):147-149.
Source ›

Chiesa M, Guimond D, Tyzio R, Pons-Bennaceur A, Lozovaya A, Burnashev N, Ferrari DC, Ben-Ari Y.
Term or preterm cesarean section delivery does not lead to long-term detrimental consequences in mice. Cerebral Cortex, 2018.
Source ›

Lozovaya N, Eftekhari S, Cloarec R, Gouty-Colomer LA, Dufour A, Riffault N, Billon-Grand M, Pons-Bennaceur A, Oumar N, Burnashev N, Ben-Ari Y, Hammond C.
GABAergic inhibition in dual-transmission cholinergic and GABAergic striatal interneurons is abolished in Parkinson disease. Nature communications, 2018; 9(1):1422
Source ›

Hadjikhani N, Johnels JA, Lassalle A, Zürcher NR, Hippolyte L, Gillberg C, Lemonnier E, Ben-Ari Y.
Bumetanide for autism: more eye contact, less amygdala activation. Scientific Reports, 2018; 8(1):3602.
Source ›

2017

Lemonnier E, Villeneuve N, Sonie S, Serret S, Rosier A, Roue M, Brosset P, Viellard M, Bernoux D, Rondeau S, Thummler S, Ravel D, Ben-Ari Y.
Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders. Translational psychiatry, 2017;7(3):1056.
Source ›

2016

Lemonnier E, Lazartigues A, Ben-Ari Y.
Treating Schizophrenia With the Diuretic Bumetanide: A Case Report. Clin Neuropharmacol., 2016; 39(2):115-7.
Source ›

Ben-Ari Y.
Progress in autism research and postgenomic studies. The Lancet Neurology, 2016; 15(2):136.
Source ›

2015

Ben-Ari Y.
GABA depolarizes immature neurons and inhibits network activity in the neonatal neocortex in vivo. Front Cell Neurosci., 2015; 9:478.
Source ›

Ben-Ari Y.
Is birth a critical period in the pathogenesis of autism spectrum disorders? Nat Rev Neurosci., 2015; 16(8):498-505.
Source ›

2014

Tyzio R, Nardou R, Ferrari DC, Tsintsadze T, Shahrokhi A, Eftekhari S, Khalilov I, Tsintsadze V, Brouchoud C, Chazal G, Lemonnier E, Lozovaya N, Burnashev N, Ben-Ari Y.
Oxytocin-Mediated GABA Inhibition During Delivery Attenuates Autism Pathogenesis in Rodent Offspring. Science, 2014; 343(6171): 675-679.
Source ›

Eftekhari S, Shahrokhi A, Tsintsadze V, Nardou R, Brouchoud C, Conesa M, Burnashev N, Ferrari DC, Ben-Ari Y.
Response to Comment on “Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring”. Science, 2014; 346(6206): 176.
Source ›

Ben-Ari Y.
The GABA excitatory/inhibitory developmental sequence: a personal journey. Neuroscience, 2014; 279:187-219.
Source ›

2013

Lemonnier E, Robin G, Degrez C, Tyzio R, Grandgeorge M, Ben-Ari Y.
Treating Fragile X syndrome with the diuretic bumetanide: a case report. Acta Paediatr. 2013; 102(6):e288-90.
Source ›

Nardou R, Ferrari DC, Ben-Ari Y.
Mechanisms and effects of seizures in the immature brain. Semin Fetal Neonatal Med., 2013; 18(4):175-84.
Source ›

2012

E Lemonnier, C Degrez, M Phelep, R Tyzio, F Josse, M Grandgeorge, N Hadjikhani and Y Ben-Ari.
A randomised controlled trial of bumetanide in the treatment of autism in children. Translational Psychiatry, 2012; 2:e202.
Source ›

Ben-Ari Y, Khalilov I, Kahle KT, Cherubini E.
The GABA excitatory/inhibitory shift in brain maturation and neurological disorders. Neuroscientist., 2012; 18(5):467-86.
Source ›

 

Awards

Conferences